chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately following the vaccination, patient complained of gagging and difficulty swallowing which lasted a few days.  Patient also complained of swollen lymph system of the left  side and soreness for three weeks following the first dose of the vaccination.  Patient self treated a heating pad.
She experienced severe pain in the head and in the foot its muscular; after the 2nd shot her experience got worsened and very bad; She experienced severe pain in the head and in the foot its muscular; after the 2nd shot her experience got worsened and very bad; She experienced severe pain in the head and in the foot its muscular; after the 2nd shot her experience got worsened and very bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 03Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE , she had her first dose somewhere in January), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), CONDITION AGGRAVATED (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 2021, outcome "not recovered" and all described as "She experienced severe pain in the head and in the foot its muscular; after the 2nd shot her experience got worsened and very bad".  Additional information: Clinical course reported as She experienced severe pain in the head and in the foot its muscular; after the 2nd shot her experience got worsened and very bad.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever; Chills; Product supply issue; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number N9CA2, expiry date 2nd July 2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced fever, chills and product supply issue. On an unknown date, the outcome of the fever, chills and product supply issue were unknown.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for the 2nd dose. The pharmacist called in to report that he had a couple come in greater than 6 months before the reporting date to receive first Shingrix immunization.  The 2nd dose was unavailable till the time of reporting. Additional details were reported as follows: The age at vaccination was not applicable for the 2nd dose. The pharmacist called in to report that he had a couple come in greater than 6 months before the reporting date to receive first Shingrix immunization.  The 2nd dose was unavailable till the time of reporting.  This case has been linked with US2019081367, reported by same reporter.
1) 1st vax 8/9/2021. Approximately 18 hours later developed severe migraine-like headache which last approximately 24 hours and slowly dissipated.  2) 2nd vax 8/30/20201. Approximately 12 hours later developed severe migraine-like headache with light sensitivity.  Approximately 24 hours after vax, joint pain in wrists and ankles. Additionally, hive-like rash on back and wrists.  Taking acetaminophen.
Onset of symptoms 11/20/08 - Present seen in ER 11/28/08 diagnosed with Henoch Schonlein purpura. Symptoms included small papable purpura on legs and buttocks. 12/30/2008 MR received for ER visitfor c/o rash. Dx:  Henoch-Schonlein Purpura. Pt presented with 1 wk hx of macular rash on legs and buttocks.
started having hallucinations and delusions, thought someone was after her, thought someone broke into the house, seeing relatives who have passed, paranoia, refers to herself as her given name not legal name, refers to an awakening, quit her job, accused coworker of harassing her, talking loudly-normally very quiet and reserved started April 13, 2021.  Symptoms escalated from 4/13 until she was involved in high speed chase on April 16, 2021, has no recollection of being involved in high speed chase.
Narrative: Patient reported feeling dizzy and nauseated 2 days after receiving 2nd dose of Pfizer vaccine. Patient requested ondansetron and mirtazapine re-fills.
1 month post vaccine administration, pt states her arm is weak, there is radiating nerve pain, she is experiencing limited mobility, pt is wearing a sling.
Information has been received from a physician concerning a 16 year old male with no pertinent medical history and no drug reactions/allergies who on 25-JUL-2008 was vaccinated subcutaneously with the second 0.5 ml dose of VARIVAX (Merck) (lot # 659952/0328X). Concomitant therapy included MENACTRA. On 04-MAR-2010 the patient experienced shingles "at spinal vertebrae L2 and L3". To treat the AE, the patient was given ZOVIRAX (manufacturer/description unspecified), an unspecified antibiotic and an unspecified steroid. At the time of the report, the patient recovered on an unspecified date. Follow up information has been received from a physician concerning a 16 year old male patient who on 25-JUL-2008 was vaccinated with second dose of VARIVAX (Merck) (lot # 659952/0328X) in his left arm. Concomitant therapy in the left arm included MENACTRA. In the afternoon of 04-MAR-2010 the patient developed shingles at L2 and L3 and got worse after 48 hours. The patient was given ZOVIRAX and ANH for secondary infection and steroids for infectious disease reaction confirmed by dermatologist. At the time of the report, the patient had recovered at unspecified date. Follow up information has been received from the physician who reported that she already sent in a form but would send it again. She did not think this qualified as an adverse event because the vaccine was given "a long time ago". She felt that this was not properly classified and thought it was being "lumped" with other reported adverse events. No additional AE information provided. Follow up information has been received from the physician concerning the patient who on 25-JUL-2008, was vaccinated with the second dose of VARIVAX (Merck) (lot # 659952/0328X) on the left. No rash occurred at the site of injection or elsewhere within 42 days of the vaccination. On 04-MAR-2010 the patient experienced herpes zoster at L2 and L3. Maximum temperature was 98.1degree F. The pain was quantified as 6 to 7. Other systemic symptoms included early cellulitis. There was not a history of chickenpox. There was no recent exposure to chickenpox or herpes zoster. Direct fluorescent antibody was not done. No specimen was collected for PCR. No photo was taken. The patient was referred to Dermatology who conferred and agreed with the diagnosis. The patient had recovered on unspecified date. Additional information is not expected.
pt recvd vax; same day, exp fever 101, ha, chills, rash & achy bones; pt required bed rest; gradually resolved;
Patients guardian falsified DOB when registering for vaccination, stating the minor's DOB was of correct age. Guardian consented to the vaccination. Department of Health verified with statistical records that the patients actual DOB is different than reported, which made the vaccine a contraindication.  No known adverse reactions noted.
IMMEDIATELY AFTER VACCINATIONS INCLUDING HPV,MENINGITIS B, MENINGITIS A, HEP A.HE FELT LIGHT HEADED,S, HE WAS SWEATY,HOT, PULSE NOT EASILY PALPALPA BLE  HEART RATE LOW. HE LAID FLAT ON THE EXAM COUCH, BP AT 1505PM 67/32 HR 40. DRANK WATER, VOMITED. REPEAT BP AT 1520 WAS 112/72 LYING DOWN HR 79. HE FELT MUCH BETTER. WAS SITTING UP HAVING CONVERSATIONS. PULSE EASILY PALPABLE OF GOOD RATE AND VOLUME. REPEAT BP AT 1535PM WAS 110/67 HR 63. REPEAT BP AT 1550PM 109/62 HR 63.
incorrect product storage; No additional adverse effect reported; This spontaneous report recibed from a nurse practitioner refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not provided.     On an unknown date, the patient was vaccinated with improperly stored doses of hepatitis a vaccine, inactivated(VAQTA) lot # T020109 expiration date 26-JAN-2022 for prophylaxis (strength, dose and route were not provided). No additional adverse effect reported.   Digital Data Logger registered a temperature excursion between 47 to 77 Fahrennheit degrees (47.7) for 20 minutes.  This is one of several reports received from the same source. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: T020109; expirationdate: 26-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2104USA002701:
uncontrollable crying >3hr hematoma @ site 4hr p/vax;
Swelling in face... also can be described as puffiness around eyes. Eyes reduced to narrow slits, but remained able to see. Child did not seem bothered by swelling. No medical intervention needed. Lasted for approximately 48 hours after vaccination.
VOICE CHANGES SOMETIMES; LUNGS HURT; COUGH; BREATHING IS GETTING WORSE/CANT GET A BREATH IN SOMETIMES; CHEST HURTS FROM COUGH; ALLERGIC REACTION; THROWING UP FROM THE COUGH; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included: cough. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and batch number: 1808980 expiry: 20-JUN-2021) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the patient experienced throwing up from the cough. On 30-MAR-2021, the patient experienced cough. On 30-MAR-2021, the patient experienced breathing is getting worse/cant get a breath in sometimes. On 30-MAR-2021, the patient experienced chest hurts from cough. On 30-MAR-2021, the patient experienced lungs hurt. On 30-MAR-2021, the patient experienced allergic reaction. On APR-2021, the patient experienced voice changes sometimes. Laboratory data (dates unspecified) included: Chest X-ray (NR: not provided) Lungs were clear. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, salbutamol, fluticasone propionate/salmeterol xinafoate, benzonatate, fluticasone, and prednisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from cough, and breathing is getting worse/cant get a breath in sometimes, and the outcome of allergic reaction, chest hurts from cough, voice changes sometimes, throwing up from the cough and lungs hurt was not reported. This report was non-serious.
Patient complains of persistent soreness since injection at injection site. Reported to us on 10-29-09.
BURSITIS TYPE IRRITATION; HEADACHE IN THE BACK OF THE HEAD ON THE RIGHT SIDE ON THE BASE OF THE SKULL AND FELT LIKE PULSATING PAIN; REDNESS OF FACE; FEVER; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's past medical history included: bursitis, and concurrent conditions included: allergy to antibiotics, environmental allergies, and drug allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included cetirizine hydrochloride for environmental allergies, and allergies to antibiotics. On 07-APR-2021, the patient experienced redness of face, and fever. On 08-APR-2021, the patient experienced bursitis type irritation, and headache in the back of the head on the right side on the base of the skull and felt like pulsating pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bursitis type irritation, redness of face, and fever on 07-APR-2021, and headache in the back of the head on the right side on the base of the skull and felt like pulsating pain on 08-APR-2021. This report was non-serious.
Pain and stiffness of left deltoid warm erythematous circular area measures 5cm approximately 4cm inferior to the injection site.
Sore arm at site, chills, extreme fatigue, no energy, no appetite . Started with just sore arm and heavy feeling arm then the next day the other symptoms started
This spontaneous report was received from a registered nurse and refers to unspecified number of patients of unknown age and gender. The patient's medical history, current conditions, drug reactions and allergies were unknown. On 09-JAN-2015, the patients were vaccinated with doses of VARIVAX (Merck) (dose, route of administration, anatomical location and exp. date were not reported) that have been exposed to a supported temperature excursion (also reported as supported defrost cycling). No adverse effects have been observed or reported. The outcome of the event was unknown. This is one of two reports received from the same source. Additional information has been requested.
(L) thigh/leg red and swollen with palpable lump. Was coughing. Taken BENADRYL orally.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 75-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included endometriosis. On 17th July 2018 13:00, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 17th July 2018 18:00, 5 hrs after receiving SHINGRIX, the patient experienced pain in arm, weakness, tremor, pain, appetite lost and feeling unwell. On an unknown date, the outcome of the pain in arm, weakness, tremor, pain, appetite lost and feeling unwell were recovered/resolved. The reporter considered the pain in arm, weakness, tremor, pain, appetite lost and feeling unwell to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on an unknown arm. In the early evening, around 6pm, the patient experienced sore in arm where she received the vaccine for several days, felt very weak, shaky, felt sick, lost her appetite and went right to bed. The patient was also shaking once in bed. The following day after receiving the vaccine, the patient still did not have an appetite but was able to walk around during the day. The patient reported these symptoms lasted about 3 to 5 days before the events resolved completely. The reporter did not consent to follow up. For tolerance to the 2nd dose of SHINGRIX refer case US2019025068, reported by same reporter. The suspect vaccine was captured as SHINGRIX vaccine instead of Flu vaccine as per the case description.
Patient received shot on 8/16/17. No problems were noted at that time or within the 15 minutes after the shots were received. Patient returned to pharmacy 8 days after shots were received complaining that 1) left arm had hurt since having shot, so much that he had to sleep in a chair, 2) left arm began to swell 3 days after receiving shots and that there was a rash, 3) patient had seen the physician assistant on 8/22/17 and received a shot "for the pain" but it didn't help. Since patient didn't know what the shot was, I called and found out that he had received a dexamethasone injection and a referral to the chiropractor. He wasn't given anything for the pain and was still complaining his arm was swollen. Office asked if he had seen the chiropractor which patient said he had but was told the chiropractor could not help. I indicated that I could not help the patient at this point beyond recommending something like Ibuprofen or BENADRYL for his reaction and pain and seeing the doctor. Office stated to please let the patient know he needed to come back to the office.
Patient admitted 3/28/2021 with severe COVID 19 pneumonia.  She progressed to acute respiratory failure and was intubated.  During her hospitalization she was diagnosed with acute myeloblastic leukemia.  Her family withdrew care and she died on 4/7/2021
After receiving the vaccine (3-5 minutes later) I had palpitations, my heart was beating very fast and a little bit of shortness of breath.   I reported it immediately and I received attention at the vaccine facility with the paramedics and the nurse in charge.  I was at the place for about 1 hour after I recovered.  I had to ask for a ride to come back home, that day I felt exhausted, very tired.  The next 5 days I felt tired but I was able to function. But the following Friday, April 2 I woke up with palpitations one more time, I went to the hospital but nothing was found, my heart apparently was fine and their diagnostic was anxiety.  I suffered it before around 15 years ago.
bones aching; woke up at 2:00AM completely soaked runing a sweat; chills; fever/temperature of 103.7; headache; pain in arm but manageable; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm but manageable), BONE PAIN (bones aching), NIGHT SWEATS (woke up at 2:00AM completely soaked runing a sweat), HEADACHE (headache) and CHILLS (chills) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in arm but manageable) and HEADACHE (headache). On 23-Apr-2021, the patient experienced BONE PAIN (bones aching), NIGHT SWEATS (woke up at 2:00AM completely soaked runing a sweat), CHILLS (chills) and PYREXIA (fever/temperature of 103.7). On 24-Apr-2021, NIGHT SWEATS (woke up at 2:00AM completely soaked runing a sweat) and CHILLS (chills) had resolved. On 25-Apr-2021, HEADACHE (headache) and PYREXIA (fever/temperature of 103.7) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in arm but manageable) had resolved and BONE PAIN (bones aching) outcome was unknown.            No concomitant and treatment medication were provided  Action taken with mRNA-1273 Moderna vaccine was Not applicable    This case was linked to MOD-2021-095535 (Patient Link).
The child received an incorrect covid vaccine. He was 12 when he received the vaccine that's approved only for ages 5-11yrs. The child didn't developed any adverse effects
8day post vax t103.6-rash covering chest, shoulders arm, back, legs & going to chin
About 2 minutes after vaccine was given the patient had feelings of syncope followed by 15 seconds of seizure like activity. Patient was taken to ER for evaluation. Patient refused treatment and only allowed heart monitor to be put on and drank oral fluids.
Case number PHEH2014US025075, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to an 81-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 03 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Pt called to cancel Rabies vaccine #3 today stating that 14 days after we gave him rabies vaccine #2 and 1 day after typhoid oral #1 (not prescribed by us) he developed swelling of his fingers, toes, hands, feet and lips, hives to his body and low grade fever. He went to a walk in clinic and was given prednisone Rx. He never took this Rx, instead took alternating doses of BENADRYL and ZYRTEC plus ZANTAC. His sx waxed and waned for 72 hours. His is almost 100% better now. He declines continuing rabies vaccine and oral typhoid and is aware of risks while traveling.
After  have the vaccine done and taking my medications, I started have hallucinations of bugs all over my skin and coming out of my skin. the hallucinations lasted for about 20 hours. Called my doctor and he had to increase one of my meds to get the hallucinations to stop.
Redness, fevered, soreness at injection site - area 3 inches across arm affected. Had some nausea and headache on day of injection but no swelling of mouth/throat. Called after 5 days - still red and fevered area on arm.
At almost 12 hours following the vaccine, fever greater than 102 degrees Fahrenheit emerged along with chills, severe muscle and joint pain (particularly in the upper- to mid-back and legs/hips), nausea, vomiting, and migraine. Treated with iburprofen and odansetron at approximately 3:30 AM. Fever, nausea, and vomiting subsided due to medication. Muscle/joint pain remained at a lessened level. High levels of fatigue emerged in the early morning hours. Took sumatriptan for migraine at around noon and again later that evening. Fever resurfaced when ibuprofen wore off around noon. Had to leave work early due to fever, muscle/joint pain, and migraine. Took another dose of ibuprofen around that time and again in the evening. Fatigue lasted until approximately 48 hours later. All other symptoms subsided within 24 hours.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 01-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Started with a slight headache that worsened to a crushing headache that felt like my head was in a vice. Lower back started hurting, followed by all joints and eventually every part of my body was in pain. 103 fever, severe chills. Sweating, nausea, shakes.
booster; covid over the break even with booster; covid over the break even with booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 44 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "covid over the break even with booster". Clinical course: Other suspect are Genotropin pen 12/12mg cartridge/0.4mg daily.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.